Posts
AMTD IDEA’s half year results announcement timing of its major subsidiary AMTD Digital
Source: PR Newswire · AMTD IDEA Group; AMTD Digital · View original releasePARIS and NEW YORK and SINGAPORE, Oct. 23, 2026 /PRNewswire/ -- AMTD Group...
Designed for Global Expectations: The First LEPAS Global Concept Car, AURA, Makes Its World Premiere
Source: PR Newswire · LEPAS · View original releaseWUHU, China, Oct. 23, 2026 /PRNewswire/ -- On October 22, the World Premiere of the LEPAS Concept...
Frost & Sullivan: Wood Coatings Market to Reach $33.34 Billion by 2032 as Sustainable and Premium Finishes Reshape Demand
Source: PR Newswire · Frost & Sullivan · View original releaseWaterborne chemistries, factory-applied systems and a steady renovation cycle are moving value toward coatings that...
Frost & Sullivan: Grid Constraints Emerge as the Binding Limit on Industrial Heat Electrification
Source: PR Newswire · Frost & Sullivan · View original releaseWith all five core technologies now commercially proven, connection queues and financing conditions have replaced...
Johnson & Johnson Deepens its Long-Term Commitment to Hong Kong Through OASES Strategic Enterprise Collaboration
Source: PR Newswire · Johnson & Johnson · View original release Building on more than five decades in Hong Kong, Johnson & Johnson is committed...
Frost & Sullivan Expands Global Research Portfolio with Extensive China Market Intelligence
Source: PR Newswire · Frost & Sullivan · View original releaseFrost & Sullivan China's specialised research platform complements Frost & Sullivan's global analytics subscription offering...
HLB Customers Can Now Scan & Pay in China with HLB QR Pay
Source: PR Newswire · Hong Leong Bank · View original releaseHLB brings greater spending certainty for customers with the ability to lock-in favorable exchange rates...
Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent
Source: PR Newswire · Menarini Industrie Farmaceutiche Riunite · View original release GIM-621 is a preclinical-stage, first-in-class oral small molecule immunotherapy with potential application across...